
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
ABOUT THE ARTIST
Giang Ho is a 2019 PharmD candidate at the University of Iowa College of Pharmacy. She grew up in Vietnam before traveling to the United States to study pharmacy. More of her comics can be read at garuscaselogs.wordpress.com or on social media under #graphicpharmacy.
over 7 years ago
Did It Make a Sound? Becoming Leaders in an Era of Quality Careover 7 years ago
Empowering Women Into Pharmacy and Health Care C-Suitesover 7 years ago
Q&A: Ohio Northern University Raabe College of Pharmacy





